Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.730
-0.040 (-1.44%)
At close: Oct 7, 2025, 4:00 PM EDT
2.728
-0.002 (-0.07%)
After-hours: Oct 7, 2025, 6:09 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $147.30 million as of October 7, 2025. Its market cap has decreased by -21.01% in one year.
Market Cap
147.30M
Enterprise Value
129.73M
1-Year Change
-21.01%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $147.30M, a decrease of -25.40%. That is a compound annual growth rate of -5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 147.30M | -3.13% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |